From our experience of extraction of TBFBs over more than a decade, we have drawn the following conclusions: (1) TBFBs present most frequently in the age group of 1 to 2 years, with cough and/or breathlessness commonly following a choking episode; (2) a high index of suspicion is essential and diagnostic FB should be performed in all such cases even though the chest radiograph is normal; (3) TBFBs can be life threatening and may require to be treated as an emergency; (4) FB may be used first for diagnosis and extraction under conscious sedation for nonasphyxiating TBFBs. It is usually more successful in adults and less so in children; (5) in these patients, if FB is unsuccessful, then RB may be used to extract the TBFB; (6) for asphyxiating TBFBs, RB is the procedure of choice; (7) pulmonologists who wish to practice extraction of TBFBs ought to be trained in both FB and RB and must possess adequate equipment and a skilled team to assist them.
The aim of this study is to assess the frequency of both physiological and pathological cutaneous lesions in first seven days of life in a tertiary care hospital of western Uttar Pradesh. Overall 500 neonates either inborn or attending paediatric OPD/ clinic and delivered in the hospital were included in the study. The study took 6 months, consent from parents of those neonates were taken. Clinical examination, dermatological examinations were carried out to check their eligibility to enter this study and to diagnose the skin lesions. Consultations to dermatologists were done in the beginning of the study, especially, in the doubtful cutaneous lesions. Skin lesions were present in 476 (95.2%) neonates. Of these 60 neonates (12%) have pathological lesions, 430(86%) had only physiological lesion, while 14 neonates (2.8%) had both physiological and pathological lesions. Of physiological lesions Epstein pearls were most common (78%) second most common lesion was Mongolian spots (65%), desquamation was seen in 52% cases, & milia (42%). Pathological lesions pustulosis was most common seen in 28% cases; second most common lesion was oral thrush (26%).
Patients with Friedreich's ataxia (FA) are at an increased risk of developing diabetes mellitus and glucose intolerance. Diabetes usually develops many years after the initial presentation. We report an 8-year-old girl who initially presented with diabetic ketoacidosis and was treated as a case of insulin-dependent diabetes mellitus. Around a year later, she developed gait problems and ataxia. Cardiac involvement was detected on echocardiography. Genetic testing confirmed the diagnosis of FA. FA should be a diagnostic consideration in children presenting with diabetes and neurological issues, even with early presentation of the former. Early occurrence of diabetes and rapid progression of ataxia in this patient needs a better understanding of underlying genetic mechanisms.
Phospholipase A2-associated neurodegeneration (PLAN) comprises of three disorders with overlapping presentations. The most common of these is classical or infantile-onset phospholipase A2-associated neurodegeneration, also known as infantile neuroaxonal dystrophy (INAD). Only 1 case of INAD has been reported from India till now. We report two genetically confirmed patients seen at a tertiary care pediatric hospital. Both these patients presented with infantile onset of neuroregression. We believe that INAD is underrecognized and underreported from India.
It is helpful if dental practitioners are able to distinguish between the cases of pericoronitis that need emergency referral to hospital and the cases that can be managed in practice and referred to an outpatient clinic.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.